Medicare, Medicaid not impacted by Trump funding freeze, Politico reports
Early Tuesday, the White House budget office circulated a 52-page document as it seeks to implement a sweeping freeze of federal assistance, ...
FTC Says UnitedHealth, CVS, Cigna Make Billions Via PBMs On Specialty Drugs
FTC report reveals significant markups by top PBMs on specialty drugs, driving $7.3 billion in revenue and raising costs for ...
Yahoo Finance12d
FTC Says CVS, Cigna and UnitedHealth Abuse Middleman Role
(Bloomberg) -- Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average acquisition cost for dozens of specialty generic drugs, bringing ...
FTC report shows $7.3 billion in drug price inflation by leading pharmacy benefit managers
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.
Newsweek on MSN12d
UnitedHealth Charged Cancer Patients 5000%, Bombshell FTC Report Claims
The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's ...
The American Journal of Managed Care11d
Insurer-PBM Firms Dominate Medicare Part D Market, Steering Patients to Their Pharmacies
Insurer-pharmacy benefit manager (PBM) firms control most of the Medicare Part D market, steering patients to their ...
United Health Lawsuit Named Among FTC's Biggest Wins
The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.
Cigna and peers gain on Elevance's positive MLR report
Elevance Health's financial outlook for FY 2025 anticipates GAAP diluted earnings per share (EPS) to be in the range of $30.40 to $31.10 and adjusted diluted EPS to be in the range of $34.15 to $34.85 ...